发明名称 |
SELECTIVE THROMBIN INHIBITORS |
摘要 |
The present invention relates to a novel selective thrombin inhibitor having the following formula (I), which is also effective by oral administration: (see fig. I) in which R1 represents acetyl substituted with aryl or aryloxy, or represents sulfonyl substituted with substituted or unsubstituted aryl or N-containing heterocyclic group, X represents a group of formula (see fig. II) or (see fig. III), R2 and R3 independently of one another represent hydrogen; cycloakyl substituted or unsubstituted with carboxyl or. alkoxycarbonyl; arylalkyloxy; hydroxy; or lower alkyl substituted or unsubstituted with carboxyl, alkoxycarbonyl. or hydroxy, or R2 and R3 together with nitrogen atom to which they are attached can form a piperidine group substituted with carboxyl or alkoxycarbonyl, R4 represents hydrogen, lower alkyl or lower alkoxy, R5 represents alkanesulfonyl; alkoxycarbonyl; alkylcarbonyl; formyl; lower alkyl; aryl substituted or unsubstituted with alkoxy or haloalkyl; or hydroxy-substituted lower alkyl, and R6 and R7 independently of one another represent hydrogen, lower alkyl or amino, and to a process for preparation thereof and a pharmaceutical composition for thrombin inhibition which comprises the compound of formula (I) as an active ingredient.
|
申请公布号 |
CA2188690(A1) |
申请公布日期 |
1998.04.23 |
申请号 |
CA19962188690 |
申请日期 |
1996.10.23 |
申请人 |
LG CHEMICAL LTD.;LG CHEMICAL LTD. |
发明人 |
JEONG, YI NA;LEE, YONG HEE;SHIN, YOU SEUNG;YUN, MI KYUNG;KIM, SANG SOO;HWANG, SANG YEUL;LEE, KOO;HWANG, SEONG RYUL;HONG, SEONG WON;OH, YEONG SOO |
分类号 |
C07C257/18;A61K31/155;A61K31/165;A61K31/18;A61K31/445;A61K31/495;A61P7/02;A61P43/00;C07C257/22;C07C311/19;C07C311/29;C07C311/42;C07C311/45;C07D211/34;C07D211/60;C07D241/04;C07D295/10;C07D295/16;C07D295/185;C07D295/205;C07D295/26;(IPC1-7):C07C311/18;A61K31/16;A61K31/195;A61K31/215;C07C311/41 |
主分类号 |
C07C257/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|